↓ Skip to main content

Evidence for harm reduction in COPD smokers who switch to electronic cigarettes

Overview of attention for article published in Respiratory Research, December 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#11 of 2,434)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

policy
2 policy sources
twitter
274 tweeters
facebook
7 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
152 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evidence for harm reduction in COPD smokers who switch to electronic cigarettes
Published in
Respiratory Research, December 2016
DOI 10.1186/s12931-016-0481-x
Pubmed ID
Authors

Riccardo Polosa, Jaymin Bhagwanji Morjaria, Pasquale Caponnetto, Umberto Prosperini, Cristina Russo, Alfio Pennisi, Cosimo Marcello Bruno

Abstract

Electronic cigarettes (ECs) are battery-operated devices designed to vaporise nicotine, which may help smokers quitting or reducing their tobacco consumption. There is a lack of data on the health effects of EC use among smokers with COPD and whether regular use results in improvement in subjective and objective COPD outcomes. We investigated long-term changes in objective and subjective respiratory outcomes in smokers with a diagnosis of COPD who quit or reduced substantially their tobacco consumption by supplementing with or converting only to ECs use. We conducted a retrospective chart review of patients with COPD to identify those reporting regular daily use of ECs on at least two follow-up visits at 12- (F/up1) and 24-months (F/up2). Regularly smoking COPD patients were included as a reference group. A marked reduction in cigarette consumption was observed in ECs users. A significant reduction in COPD exacerbations was reported in the COPD EC user group, their mean (±SD) decreasing from 2.3 (±1) at baseline to 1.8 (±1; p = 0.002) and 1.4 (±0.9; p < 0.001) at F/up1 and F/up2 respectively. A significant reduction in COPD exacerbations was also observed in ECs users who also smoked conventional cigarettes (i.e. 'dual users'). COPD symptoms and ability to perform physical activities improved statistically in the EC group at both visits, with no change in the control group. These findings suggest that ECs use may aid smokers with COPD reduce their cigarette consumption or remain abstinent, which results in marked improvements in annual exacerbation rate as well as subjective and objective COPD outcomes.

Twitter Demographics

The data shown below were collected from the profiles of 274 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 152 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 17%
Student > Master 25 16%
Researcher 19 13%
Other 11 7%
Student > Doctoral Student 10 7%
Other 26 17%
Unknown 35 23%
Readers by discipline Count As %
Medicine and Dentistry 38 25%
Nursing and Health Professions 14 9%
Psychology 14 9%
Pharmacology, Toxicology and Pharmaceutical Science 13 9%
Biochemistry, Genetics and Molecular Biology 8 5%
Other 27 18%
Unknown 38 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 193. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2021.
All research outputs
#133,675
of 20,072,700 outputs
Outputs from Respiratory Research
#11
of 2,434 outputs
Outputs of similar age
#4,267
of 413,320 outputs
Outputs of similar age from Respiratory Research
#2
of 129 outputs
Altmetric has tracked 20,072,700 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,434 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,320 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 129 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.